国药现代（600420）2025年度权益分派实施公告详细解读
一、公告要点概览
- 每股分红：每股派发现金红利0.20元（含税）。
- 权益登记日：2026年6月2日。
- 除权（息）日及现金红利发放日：2026年6月3日。
- 总分红金额：合计派发现金红利人民币268,234,538.40元。
- 分红方案已获批准：2025年年度股东大会于2026年5月8日审议通过。
- 差异化分红送转：否。
二、分配对象与实施办法详细说明
- 分红对象为截至2026年6月2日（股权登记日）下午上海证券交易所收市后登记在册的全体股东。
- 无限售条件流通股的红利，将通过中国证券登记结算有限责任公司上海分公司资金清算系统发放。
- 已办理指定交易的投资者可于红利发放日在其指定的证券营业部领取现金红利，未办理指定交易的暂由中登上海分公司保管，待办理指定交易后发放。
- 部分大股东（如中国医药集团有限公司、上海医药工业研究院有限公司等）由公司直接派发红利。
三、红利发放的税务处理细则
- 个人股东与证券投资基金：
– 持股期限超过1年，红利所得暂免征收个人所得税，每股实际到手0.20元。
– 持股期限1年及以下，公司暂不扣税，红利全额发放，待卖出时由券商代扣税（1个月及以下实际税负20%，1个月以上至1年实际税负10%）。 - QFII（合格境外机构投资者）：统一按10%税率代扣代缴企业所得税，每股实际派发0.18元。如需享受税收协定待遇，须自行向税务机关申请。
- 沪港通投资者（包括企业及个人）：按10%税率代扣代缴所得税，扣税后每股实际派发0.18元。
- 其他机构投资者及法人股东：公司不代扣代缴企业所得税，由投资者自行申报缴纳，实际派发每股0.20元。
四、对投资者的影响及潜在股价影响因素
- 稳定分红政策：本次分红显示公司持续稳定的盈利能力和对股东回报的重视，有利于增强市场信心。
- 分红收益率：投资者可根据0.20元/股的分红与当前股价测算分红收益，或将吸引长期价值投资者关注。
- 税收政策对持股结构影响：因税负与持股期限相关，可能影响投资者持股行为，短线投资者需关注税务影响。
- 红利发放时间节点明确：有助于投资者提前做好资金安排，捕捉红利行情。
五、投资者需重点关注事项
- 股权登记日为2026年6月2日，仅在该日收市时登记在册的股东方可参与本次分红。
- 除权（息）日及红利发放日均为2026年6月3日，需关注股价因除权调整的短期波动。
- 未办理指定交易的股东需尽快办理，否则红利将暂由中登上海分公司保管。
- 投资者需根据自身税务身份与持股期限，合理安排投资计划。
- 如有疑问，可联系公司董事会办公室（电话：021-52372865）。
六、结论
本次分红方案显示国药现代经营稳健，现金流充裕，分红收益在当前市场环境下具备一定吸引力。分红发放的时间与税务政策细节清晰，投资者应根据自身持股计划和税务状况，合理安排投资。长期持有者将享受免税红利，短期持有者需关注税负影响。公司持续、透明的分红政策有望提升市场信心，对股价有正面催化作用，建议关注后续市场表现和相关公告。
免责声明：本文仅为公告解读及信息汇总，不构成任何投资建议。投资者据此操作，风险自负。请结合自身情况及市场环境审慎决策。
English Version
Sinopharm Modern (600420) 2025 Annual Dividend Distribution Implementation Notice – In-depth Analysis
1. Key Points Overview
- Dividend per Share: RMB 0.20 (pre-tax) per share.
- Record Date: June 2, 2026.
- Ex-dividend and Dividend Payment Date: June 3, 2026.
- Total Dividend Amount: RMB 268,234,538.40 in total cash dividends.
- Plan Approval: Approved at the 2025 Annual Shareholders’ Meeting on May 8, 2026.
- No Differential Bonus Share Plan: Confirmed as “No”.
2. Details on Distribution Targets and Implementation
- All shareholders registered at China Securities Depository and Clearing Corporation Shanghai Branch after market close on the record date (June 2, 2026) are entitled to the dividend.
- Dividends for tradable shares with no sales restrictions are distributed via the clearing system of the Shanghai branch of CSDC.
- Investors with designated trading accounts will receive cash dividends at their designated securities branches; otherwise, CSDC Shanghai will hold the dividends until designation is completed.
- Major shareholders (e.g., China National Pharmaceutical Group Co., Ltd., Shanghai Institute of Pharmaceutical Industry, etc.) will receive dividends directly from the company.
3. Taxation Details
- Individual Shareholders & Securities Investment Funds:
– Holding period >1 year: Dividends are tax exempt, net receipt RMB 0.20 per share.
– Holding period ≤1 year: Company does not withhold tax, full dividend paid; tax will be withheld by brokers upon sale (20% if held ≤1 month, 10% if held >1 month to 1 year). - QFII (Qualified Foreign Institutional Investors): 10% withholding tax rate, net dividend RMB 0.18 per share. For treaty benefits, QFII must apply to the tax authorities.
- Hong Kong Stock Connect Investors (individuals and enterprises): 10% withholding tax, net dividend RMB 0.18 per share.
- Other Institutional & Corporate Shareholders: Company does not withhold, shareholders self-declare and pay tax, net dividend RMB 0.20 per share.
4. Potential Impact on Investors and Share Price
- Stable Dividend Policy: Indicates solid profitability and consistent shareholder returns, likely to boost market confidence.
- Dividend Yield: Investors can estimate yield based on current share price, potentially attracting value-focused investors.
- Tax Policy Influences: As tax burden depends on holding period, investor behavior may be affected, especially for short-term holders.
- Clear Distribution Timeline: Enables investors to plan for cash flows and capture dividend opportunities.
5. Important Notes for Shareholders
- Only shareholders on record at the close of June 2, 2026, will be eligible for the dividend.
- Ex-dividend and payment date is June 3, 2026; watch for short-term price fluctuations due to the ex-dividend adjustment.
- Shareholders without designated trading must complete it to receive dividends; otherwise, dividends are temporarily held by CSDC Shanghai.
- Investors should consider their tax identity and holding period when planning investments.
- Contact the Board Office for inquiries (Tel: 021-52372865).
6. Conclusion
This dividend plan demonstrates Sinopharm Modern’s stable operations, strong cash flow, and attractive shareholder returns in the current market. Clear timelines and taxation policies are laid out. Long-term holders enjoy tax-free dividends; short-term holders should watch for tax implications. The company’s continuous and transparent dividend policy is likely to positively impact market sentiment and share price. Investors should monitor follow-up disclosures and market response.
Disclaimer: This article is for information and analysis only and does not constitute investment advice. Please assess your own situation and the market environment before making investment decisions. All risks are borne by the investor.
